Moleculin Biotech (MBRX) Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial
Go back to Moleculin Biotech (MBRX) Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 4.28 -0.07 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.35 | 52 Week High | $9.58 | |||
| Open | $4.30 | 52 Week Low | $2.34 | |||
| Day High | $4.50 | P/E | N/A | |||
| Day Low | $4.28 | EPS | $-0.34 | |||
| Volume | 11,065 | |||||
